BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 3
• 4
• 7
• 8
• 9
• 10
• 11
• 14
• 15
• 16
• 17
• 18
• 21
• 22
• 23
• 24
• 25
• 28
• 29
• 30

• Drug Development

  Ariad Pharmaceuticals, Inc. Presents Updated Clinical Data on Its Investigational Pan-BCR-ABL Inhibitor, AP24534, in Drug-Resistant Chronic Myeloid Leukemia

  June 7, 2010

   · 

  1 min read
• Business

  PDI, Inc. Appoints Gerald P. Belle to Chairman of the Board

  June 7, 2010

   · 

  3 min read
• Biotech Beach

  Vical Incorporated to Present at Two Upcoming Investor Conferences

  June 7, 2010

   · 

  1 min read
• Drug Development

  Human Genome Sciences, Inc. Announces Submission of Marketing Authorization Application to European Medicines Evaluation Agency for BENLYSTA(R) (Belimumab)

  June 7, 2010

   · 

  1 min read
• Drug Development

  American Society of Clinical Oncology Announces Presentations of Phase 2 Data of Azixa(TM) Demonstrating Durable Responses in Patients With Glioblastoma Multiforme and Metastatic Melanoma at American Society of Clinical Oncology 2010

  June 7, 2010

   · 

  1 min read
• Business

  Paul L. Berns Joins Jazz Pharmaceuticals, Inc.'s Board of Directors

  June 7, 2010

   · 

  1 min read
• BioMidwest

  Vivakor, Inc. Announces Receipt of LOI for $600k Investment

  June 7, 2010

   · 

  1 min read
• Drug Development

  Millennium: The Takeda Oncology Company Release: Oral Presentations Showcase Impressive Results of VELCADE(R) (bortezomib) Based Therapy in Multiple Myeloma

  June 7, 2010

   · 

  1 min read
• Drug Development

  Genentech Release: Phase III Study Showed Avastin-Based Regimen Helped Women with Advanced Ovarian Cancer Live Longer Without Their Disease Worsening

  June 7, 2010

   · 

  1 min read
• Drug Development

  Progenics Pharmaceuticals, Inc. Phase 1 PSMA ADC Study Presented in New “Trials in Progress” Poster Session at American Society of Clinical Oncology Annual Meeting

  June 7, 2010

   · 

  1 min read